| NURO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NURO shares outstanding history going back to 5/12/2017:
Also see: NURO Market Cap History NURO YTD Return |
NURO Shares Outstanding History — NeuroMetrix Share Count Over Time
As of 3/28/2025 NeuroMetrix has 2.06 million NURO shares outstanding. Investors often track the NURO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NURO share count trends over time, with 33 historical shares outstanding datapoints presented, dating back to 5/12/2017.
| NURO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NURO Historical Shares Outstanding: +85.42% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NURO Stock Price Chart |
| About NeuroMetrix Inc |
| NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. Co.'s products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. Co. has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. It operates two product categories: Diagnostic technology and Therapeutic technology. We show 33 historical shares outstanding datapoints in our coverage of NURO's shares outstanding history. Understanding the changing numbers of NURO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NURO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NURO by allowing them to research NURO shares outstanding history as well as any other stock in our coverage universe. |
| NURO Current Stock Quote |
Quotes delayed 20 minutes  Free NURO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| NURO Share Performance |
| Shares Outstanding Peers |
| NeuroMetrix (NURO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
NUTX Shares Outstanding History NUVA Shares Outstanding History NUVB Shares Outstanding History NUVL Shares Outstanding History NUWE Shares Outstanding History NVAX Shares Outstanding History NVCT Shares Outstanding History NVIV Shares Outstanding History NVNO Shares Outstanding History NVO Shares Outstanding History More Healthcare companies » |
NURO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
